A step-by-step video demonstration of the preparation and administration of MIGRANAL.
You are solely responsible for your interactions with that website.
A no-cost solution for providers and their staff
Submit one request for Dihydroergotamine Mesylate
for all plans
Save ~15 minutes per PA request by eliminating calls and faxes
Automatically renew previously submitted PA requests
A quick guide to the simple steps
for preparing and administering
Savings and support are available for eligible* commercially insured patients taking brand-name MIGRANAL and the authorized generic from the makers of MIGRANAL.
*Maximum benefits apply. For eligible commercially insured patients only.
For full eligibility requirements/terms and conditions, please see Patient Savings tab above.
Share this checklist with your patients to help them determine how well their medication is working.
MIGRANAL® (dihydroergotamine mesylate) Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura. MIGRANAL Nasal Spray is not intended for the prophylactic therapy of migraine or for the management of hemiplegic or basilar migraine.
Serious and/or life-threatening peripheral ischemia has been associated with the coadministration of DIHYDROERGOTAMINE with potent CYP3A4 inhibitors including protease inhibitors and macrolide antibiotics. Because CYP3A4 inhibition elevates the serum levels of DIHYDROERGOTAMINE, the risk for vasospasm leading to cerebral ischemia and/or ischemia of the extremities is increased. Hence, concomitant use of these medications is contraindicated.
Please click here for full Prescribing Information for MIGRANAL Nasal Spray, including Boxed Warning and Patient Information.